Begrocit, Brausetabletten

7680363270147 CH-36327 Brausetabletten

Associated product:

BEGROCIT cpr eff fl 10 pce
Begrocit, Brausetabletten
Begrocit, Brausetabletten
Begrocit, Brausetabletten
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Tablette(n)
Galenic form
Brausetabletten
Galenic group
Brausetabletten

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
15.0 MG Substance Wirkstoff (Principe actif)
(N/A)
15.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
0.15 MG Substance Wirkstoff (Principe actif)
acidum pantothenicum
23.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
1.0 G Substance Wirkstoff (Principe actif)
(N/A)
117.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance WIZUS
calcii pantothenas
- Substance WIZUS
natrii hydrogenocarbonas
- Substance HNIDK
acidum citricum
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
povidonum K 30
- Substance HNIDK
(N/A)
- Substance HIMDK
silica colloidalis anhydrica
- Substance HNIDK
aromatica
- Substance AROMA
natrium
358.0 MG Substance HBESI

Authorization holder

HELP Pharma Switzerland AG

4051 Basel

Authorization information

Swissmedic authorization number
36327
Drug name
Begrocit, Brausetabletten
Galenic form
BRAT
ATC Code
A11EX
Authorization status
Z
Dispensing category
D
First authorization
18/10/1971
Authorization expiration date
31/12/9999
IT Number
07.02.51
Domain
Human medicine
Field of application
Vitamin B-Komplex-Präparat mit Vitamin C und Calcium

Package details

Description (FR)
BEGROCIT cpr eff fl 10 pce
Description (DE)
BEGROCIT Brausetabl Fl 10 Stk
Market launch
18/10/1971
Narcotic (BTM)
No